Stay updated on Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Sign up to get notified when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now shows that no participants are being sought, updating the recruitment status to completed. Additionally, new help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a small formatting change updated the Intervention/Treatment label while the site revision progressed from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:38:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating an update to the page's versioning.
    Difference
    0.1%
    Check dated 2026-06-05T15:51:50.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A newer revision tag was added (v3.5.4) and the previous revision tag (v3.5.3) was removed, signaling an updated version of the study record.
    Difference
    0.1%
    Check dated 2026-05-15T06:51:35.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page footer’s site revision indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a platform/release change rather than any change to the trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:36:35.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:54:36.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:40:41.000Z thumbnail image

Stay in the know with updates to Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.